Isatuximab Quadruplet Approval Could Change the Landscape for Treating MyelomaOctober 7, 2024Multiple MyelomaTransplantation
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMyelodysplastic SyndromeTransplantation
REACH2: Ruxolitinib outperformed control treatment for refractory acute GVHDApril 22, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Phase 2 study shows regimen benefit with dasatinib in Ph+ALL therapyJanuary 22, 2020ALLTransplantation
CAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020TransplantationLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Myeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019TransplantationMultiple MyelomaLymphoma & Plasma Cell Disorders
First NCCN guideline on hematopoietic cell transplantation focuses on GVHDNovember 5, 2019Transplantation
Hematopoietic cell transplant offers realistic cure in secondary AMLOctober 23, 2019AMLTransplantationLeukemia, Myelodysplasia, Transplantation
Ongoing research aims to improve transplant outcomes in sickle cellSeptember 26, 2019AnemiaTransplantation
Several factors may affect immune suppression discontinuation after HCTSeptember 26, 2019TransplantationLeukemia, Myelodysplasia, Transplantation
ASCT may cure follicular lymphoma for some rituximab-naive patientsSeptember 24, 2019TransplantationLymphoma & Plasma Cell Disorders
Could home care replace inpatient HSCT?September 18, 2019TransplantationDLBCLLymphoma & Plasma Cell Disorders
VRD pretransplant induction deepens responses in myelomaSeptember 17, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersTransplantation
